
P746: COMBINATION OF RAS/MAPK MODULATOR AND AZACITIDINE AFFECTS HISTONE MARKS AND IMPACTS THE INNATE IMMUNE SIGNALING PATHWAY IN THE MDS‐L CELL LINE
Author(s) -
Rai R.,
Patel F.,
Feld J.,
Melana S.,
Navada S.,
OdchimarReissig R.,
Demakos E.,
Reddy E. P.,
Horowitz A.,
Silverman L.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845868.83865.0c
Subject(s) - mapk/erk pathway , cancer research , innate immune system , decitabine , medicine , myeloid leukemia , myeloid , signal transduction , immune system , immunology , biology , microbiology and biotechnology , dna methylation , gene expression , biochemistry , gene